Valuation: Sagittarius Life Science Corp

Market Cap 3.14B 98.66M 88.15M 82.25M 74.7M 141M 9.54B 142M 988M 386M 4.85B 370M 362M 15.6B P/E 2024
-21.4x
P/E 2025 -55.9x
Enterprise Value 2.34B 73.46M 65.64M 61.24M 55.62M 105M 7.11B 106M 736M 287M 3.61B 276M 270M 11.62B EV / Sales 2024
1.9x
EV / Sales 2025 7.69x
Free-Float
29.82%
Yield 2024 *
-
Yield 2025 -
08-14 Sagittarius Life Science Corp Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026 CI
05-14 Sagittarius Life Science Corp Reports Earnings Results for the First Quarter Ended March 31, 2026 CI
03-16 Sagittarius Life Science Corp Reports Earnings Results for the Full Year Ended December 31, 2025 CI
11-13 Sagittarius Life Science Corp Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2025 CI
25-08-12 Sagittarius Life Science Corp Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2025 CI
25-05-14 Sagittarius Life Science Corp Reports Earnings Results for the First Quarter Ended March 31, 2025 CI
25-03-12 Sagittarius Life Science Corp Reports Earnings Results for the Full Year Ended December 31, 2024 CI
24-11-13 Sagittarius Life Science Corp Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2024 CI
24-08-13 Sagittarius Life Science Corp Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2024 CI
24-05-14 Sagittarius Life Science Corp Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
24-03-21 Sagittarius Life Science Corp Reports Earnings Results for the Full Year Ended December 31, 2023 CI
23-11-13 Sagittarius Life Science Corp Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023 CI
23-08-13 Sagittarius Life Science Corp Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023 CI
1 day-0.21%
1 week+0.32%
Current month+0.21%
1 month+1.52%
3 months-10.15%
6 months-22.99%
Current year-8.58%
1 week 46.5
Extreme 46.5
47.4
1 month 46
Extreme 46
48
Current year 45.8
Extreme 45.8
67
1 year 43.95
Extreme 43.95
67
3 years 21.3
Extreme 21.3
67
5 years 20.65
Extreme 20.65
79.2
10 years 20.65
Extreme 20.65
158
Manager TitleAgeSince
Chief Executive Officer - 2019-09-29
Director of Finance/CFO - 2019-11-14
Director TitleAgeSince
Chairman - 2004-04-28
Director/Board Member - 2015-06-16
Director/Board Member - 2004-04-28
Change 5-day change 1-year change 3-year change Capi.($)
-0.21%+0.32%-13.15%+10.09% 98.66M
+0.48%-0.61%+1.44%-24.67% 233B
-0.40%+2.70%-5.14%-6.28% 75.79B
+0.01%+0.80%+69.44%+527.92% 44.96B
-0.07%+0.14%-18.52%+14.56% 42.32B
-1.06%+2.47%+29.34%+11.64% 39.2B
-0.77%+3.74%+24.17%+78.91% 32.27B
-0.29%+1.73%-17.52%-17.79% 32.22B
+0.79%+0.79%-14.86%-12.69% 28.39B
+1.06%+1.70%+13.42%+16.66% 26.33B
Average -0.06%+0.73%+6.86%+59.84% 55.47B
Weighted average by Cap. +0.09%+0.46%+6.45%+37.20%

Financials

2024 2025
Net sales 468M 14.68M 13.11M 12.24M 11.11M 20.93M 1.42B 21.09M 147M 57.44M 722M 55.1M 53.91M 2.32B 346M 10.86M 9.7M 9.05M 8.22M 15.49M 1.05B 15.6M 109M 42.5M 534M 40.77M 39.89M 1.72B
Net income -48.53M -1.52M -1.36M -1.27M -1.15M -2.17M -147M -2.19M -15.25M -5.96M -74.92M -5.72M -5.59M -241M -49.56M -1.56M -1.39M -1.3M -1.18M -2.22M -150M -2.23M -15.58M -6.09M -76.51M -5.84M -5.71M -246M
Net Debt -150M -4.71M -4.21M -3.93M -3.57M -6.72M -456M -6.77M -47.19M -18.44M -232M -17.69M -17.3M -745M -803M -25.2M -22.52M -21.01M -19.08M -35.94M -2.44B -36.21M -252M -98.63M -1.24B -94.61M -92.57M -3.99B
Projected Income Statement - Annual - Sagittarius Life Science Corp
Logo Sagittarius Life Science Corp
Sagittarius Life Science Corp. is a Taiwan-based company principally engaged in the research, development, production and sales of health products. The Company's main products include various types of nutrition and health formulations, natural and organic food, beverages, probiotic fermentation products, beauty care ingredients, Chinese herbal medicines, plant new medicines and health supplies. The Company also provides related technical services for the research and development of Chinese and western pharmaceutical products. The Company distributes its products in domestic market and to overseas markets, such as the rest areas of Asia and the Americas.
Employees
112
Date Price Change Volume
26-10-07 NT$46.55 -0.75% 35,123
26-10-06 NT$46.90 -0.21% 11,062
26-10-05 NT$47.00 -0.42% 25,760
26-10-02 NT$47.20 +1.07% 28,276
26-10-01 NT$46.70 -0.21% 18,714
  1. Stock Market
  2. Stocks
  3. 3205 Stock